{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "10956-501",
      "generic_name": "Aspirin and Caffeine",
      "labeler_name": "Reese Pharmaceutical Co",
      "brand_name": "Reese Headache Powders",
      "active_ingredients": [
        {
          "name": "CAFFEINE",
          "strength": "65 mg/1"
        },
        {
          "name": "ASPIRIN",
          "strength": "845 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "10956-501-18",
          "description": "18 PACKET in 1 CARTON (10956-501-18)  / 1 POWDER in 1 PACKET",
          "marketing_start_date": "20200722",
          "sample": false
        },
        {
          "package_ndc": "10956-501-24",
          "description": "24 PACKET in 1 CARTON (10956-501-24)  / 1 POWDER in 1 PACKET",
          "marketing_start_date": "20200722",
          "sample": false
        },
        {
          "package_ndc": "10956-501-50",
          "description": "50 PACKET in 1 CARTON (10956-501-50)  / 1 POWDER in 1 PACKET",
          "marketing_start_date": "20200722",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Reese Pharmaceutical Co"
        ],
        "rxcui": [
          "994435"
        ],
        "spl_set_id": [
          "386f7a6c-4bfc-4140-a67b-07f6b520d58f"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175739",
          "N0000175729",
          "N0000175790",
          "M0023046",
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832"
        ],
        "pharm_class_epc": [
          "Central Nervous System Stimulant [EPC]",
          "Methylxanthine [EPC]",
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]"
        ],
        "pharm_class_pe": [
          "Central Nervous System Stimulation [PE]",
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]"
        ],
        "pharm_class_cs": [
          "Xanthines [CS]",
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "unii": [
          "3G6A5W338E",
          "R16CO5Y76E"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "POWDER",
      "spl_id": "59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20200722",
      "product_id": "10956-501_59f6b9f3-3f6d-44c4-a7f3-29fe49cf97bc",
      "application_number": "M013",
      "brand_name_base": "Reese Headache Powders",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Central Nervous System Stimulant [EPC]",
        "Central Nervous System Stimulation [PE]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Methylxanthine [EPC]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]",
        "Xanthines [CS]"
      ]
    }
  ]
}